134 related articles for article (PubMed ID: 31797842)
1. Expression of Yes-associated Protein in Oral Squamous Cell Carcinoma.
Shelke P; Sarode GS; Sarode SC; Maniyar N; Prajapati G; Patil S
J Contemp Dent Pract; 2019 Aug; 20(8):887-892. PubMed ID: 31797842
[TBL] [Abstract][Full Text] [Related]
2. Yes-associated protein promotes cell migration via activating Wiskott-Aldrich syndrome protein family member 1 in oral squamous cell carcinoma.
Qi L; Shi C; Li J; Xu S; Han Y; Li J; Zhang L
J Oral Pathol Med; 2019 Apr; 48(4):290-298. PubMed ID: 30697796
[TBL] [Abstract][Full Text] [Related]
3. Oral squamous cell carcinoma in the background of oral submucous fibrosis is a distinct clinicopathological entity with better prognosis.
Gadbail AR; Chaudhary M; Gawande M; Hande A; Sarode S; Tekade SA; Korde S; Zade P; Bhowate R; Borle R; Patil S
J Oral Pathol Med; 2017 Jul; 46(6):448-453. PubMed ID: 28129456
[TBL] [Abstract][Full Text] [Related]
4. LATS2 induced by TNF-alpha and inhibited cell proliferation and invasion by phosphorylating YAP in oral squamous cell carcinoma.
Dong C; Wei KJ; Zhang WB; Sun H; Pan HY; Zhang L
J Oral Pathol Med; 2015 Jul; 44(6):475-81. PubMed ID: 25782587
[TBL] [Abstract][Full Text] [Related]
5. Staging significance of bone invasion in small-sized (4cm or less) oral squamous cell carcinoma as defined by the American Joint Committee on Cancer.
Kuk SK; Yoon HJ; Hong SD; Hong SP; Lee JI
Oral Oncol; 2016 Apr; 55():31-6. PubMed ID: 26880520
[TBL] [Abstract][Full Text] [Related]
6. GPR39 Overexpression in OSCC Promotes YAP-Sustained Malignant Progression.
Jiang Y; Li T; Wu Y; Xu H; Xie C; Dong Y; Zhong L; Wang Z; Zhao H; Zhou Y; Li J; Ji N; Zeng X; Feng X; Chen Q
J Dent Res; 2020 Jul; 99(8):949-958. PubMed ID: 32325008
[TBL] [Abstract][Full Text] [Related]
7. Yes-associated protein promotes cell proliferation by activating Fos Related Activator-1 in oral squamous cell carcinoma.
Zhang L; Ye DX; Pan HY; Wei KJ; Wang LZ; Wang XD; Shen GF; Zhang ZY
Oral Oncol; 2011 Aug; 47(8):693-7. PubMed ID: 21708480
[TBL] [Abstract][Full Text] [Related]
8. Analysis and Comparison of the 8th Edition American Joint Committee on Cancer (AJCC) Nodal Staging System in Cutaneous and Oral Squamous Cell Cancer of the Head and Neck.
Moeckelmann N; Ebrahimi A; Dirven R; Liu J; Low TH; Gupta R; Ashford B; Ch'ng S; Palme CE; Clark JR
Ann Surg Oncol; 2018 Jun; 25(6):1730-1736. PubMed ID: 29352431
[TBL] [Abstract][Full Text] [Related]
9. [Expression of Prion protein and its clinical significance in oral squamous cells carcinoma and oral leukoplakia].
Zhang J; Zeng Y; Zheng J; Xu J
Zhonghua Kou Qiang Yi Xue Za Zhi; 2013 Dec; 48(12):752-4. PubMed ID: 24495728
[TBL] [Abstract][Full Text] [Related]
10. The role of YAP in the control of the metastatic potential of oral cancer.
Ahmad US; Saravanan K; Wan H
Oncol Res; 2021; 29(6):377-391. PubMed ID: 37304649
[TBL] [Abstract][Full Text] [Related]
11. Ki-67 Prognostic Value in Different Histological Grades of Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Takkem A; Barakat C; Zakaraia S; Zaid K; Najmeh J; Ayoub M; Seirawan MY
Asian Pac J Cancer Prev; 2018 Nov; 19(11):3279-3286. PubMed ID: 30486632
[TBL] [Abstract][Full Text] [Related]
12. Prognostic implications of the 8th edition American Joint Committee on Cancer (AJCC) staging system in oral cavity squamous cell carcinoma.
Moeckelmann N; Ebrahimi A; Tou YK; Gupta R; Low TH; Ashford B; Ch'ng S; Palme CE; Clark JR
Oral Oncol; 2018 Oct; 85():82-86. PubMed ID: 30220324
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of survivin as a prognostic marker in oral squamous cell carcinoma.
Kim YH; Kim SM; Kim YK; Hong SP; Kim MJ; Myoung H
J Oral Pathol Med; 2010 May; 39(5):368-75. PubMed ID: 20050981
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor formation and invasion and predicts poor prognosis in oral squamous cell carcinoma.
Lin CY; Chen ST; Jeng YM; Yeh CC; Chou HY; Deng YT; Chang CC; Kuo MY
J Oral Pathol Med; 2011 Oct; 40(9):699-705. PubMed ID: 23647076
[TBL] [Abstract][Full Text] [Related]
15. [Expression and significance of YAP and TAZ proteins in oral squamous cell carcinoma].
Tu MS; Li YS; Zhang X
Shanghai Kou Qiang Yi Xue; 2018 Aug; 27(4):415-418. PubMed ID: 30483712
[TBL] [Abstract][Full Text] [Related]
16. Induction of apoptosis using ATN as a novel Yes-associated protein inhibitor in human oral squamous cell carcinoma cells.
Chu PC; Dokla EME; Hu JL; Weng JR
Environ Toxicol; 2022 Jun; 37(6):1404-1412. PubMed ID: 35212453
[TBL] [Abstract][Full Text] [Related]
17. C-MYC and BCL-2 mediate YAP-regulated tumorigenesis in OSCC.
Chen X; Gu W; Wang Q; Fu X; Wang Y; Xu X; Wen Y
Oncotarget; 2018 Jan; 9(1):668-679. PubMed ID: 29416644
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Broder's and Bryne's Grading System for Oral Squamous Cell Carcinoma With Lymph Node Metastases and Prognosis: A Scoping Review.
Thamilselvan S; Pandiar D; Krishnan RP; Ramalingam K; Pavithran P
Cureus; 2024 Jan; 16(1):e51713. PubMed ID: 38313967
[TBL] [Abstract][Full Text] [Related]
19. To evaluate an association between prognostic significance of Moesin with histopathological grading of oral squamous cell carcinoma: A systematic review.
Bommanavar S; Kanetkar SR; Datkhile KD
J Oral Maxillofac Pathol; 2023; 27(1):148-161. PubMed ID: 37234334
[TBL] [Abstract][Full Text] [Related]
20. Decreased expression of SOX7 induces cell proliferation and invasion and correlates with poor prognosis in oral squamous cell carcinoma.
Oh KY; Hong KO; Huh YS; Lee JI; Hong SD
J Oral Pathol Med; 2017 Oct; 46(9):752-758. PubMed ID: 28266739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]